Hayfin Capital Management
Overview
Hayfin Capital Management is a leading European alternative asset management platform, providing critical debt, equity and hybrid capital solutions to meet a range of financing needs for both corporates (sponsor and non-sponsor) and real asset owners. Hayfin focuses on delivering attractive risk-adjusted returns for its investors across its private debt, liquid credit and private equity solutions.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Juvisé Pharmaceuticals | Feb 2026 | Debt | Lead |
| Lanas Healthcare Technology | Nov 2025 | Corporate Funding | Co-investor |
| Netceed | Oct 2025 | Debt | Lead |
| Scutum Group | Jul 2025 | Debt | Co-investor |
| SERB | Jul 2025 | Debt | Co-investor |
Key People
Alban Senlis
Managing Director
Albert Martienssen
Managing Director
Alex Cobb
Portfolio Manager, Managing Director
Andreas Esau
Managing Director
Barrett Polan
Managing Director
Clement Le Lagadec
Managing Director
David Schmookler
Managing Director
Diego Jimenez-Blanco
Managing Director
Glenn C.
Head Of Asia Pacific, Institutional Portfolio Manager, Managing Director
Gregg Drennan
Managing Director
Marc Chowrimootoo
Portfolio Manager And Managing Director
Marco Ferrari
Managing Director
Matthew Field
Managing Director
Maura English
Managing Director, Partner Solutions
Michael Tischler
Managing Director, Healthcare
Rehan Jiwani
Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
